Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Tuberous Sclerosis × Vigabatrin × Clear all

Phase

Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Tuberous Sclerosis 1

Interventions

Sirolimus 6 Everolimus 4 ganaxolone 1 dactolisib 1 Vigabatrin 1 Propranolol 1 Aspirin 1 Anticonvulsants 1 2-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl)pyridine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02849457 2024-08-19

Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex

University of Alabama at Birmingham

Phase 2 Completed

84 enrolled 16 charts

Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡